Novelos Therapuetics Inc., a publicly traded developer of drugs for the treatment and diagnosis of cancer, has changed its name to Cellectar Biosciences Inc. Cellectar is in the process of moving its headquarters back to Madison from Newton, Mass. The company was founded in Madison in 2003 by University of Wisconsin-Madison professor Jamey Weichert. Read the full Milwaukee Journal Sentinel story here.